We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.00 | 5.19% | 40.50 | 40.00 | 41.00 | 40.50 | 38.50 | 38.50 | 162,605 | 15:42:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 98.78 | 50.96M |
TIDMVLG
RNS Number : 3240N
Venture Life Group PLC
07 August 2017
7 August 2017
Venture Life Group plc
("Venture Life" or "the Company")
Director/PDMR Shareholding
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it was notified on 7 August 2017 that Peter Bream, a Non-Executive Director of the Company, has purchased 25,000 ordinary shares of 0.3p each in the Company at an average price of 62.6p per share. Following the transaction Mr Bream has a beneficial interest in 25,000 ordinary shares representing 0.07 per cent. of the Company's issued share capital.
Enquiries:
+44 (0) 1344 Venture Life Group PLC 742870 Jerry Randall, Chief Executive Officer Adrian Crockett, Chief Financial Officer Northland Capital Partners Limited (Nominated Adviser +44 (0) 20 and Joint Broker) 3861 6625 Matthew Johnson / Edward Hutton / Margarita Mitropoulou (Corporate Finance) Bob Pountney / John Howes (Corporate Broking) +44 (0) 20 Turner Pope Investments (TPI) Ltd (Joint Broker) 3621 4120 James Pope / Ben Turner Walbrook PR venturelife@walbrookpr.com or + 44 (0) 20 7933 8780 Paul McManus / Anna Dunphy +44 (0) 7980 541 893 / +44 (0) 7876 741 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
1 Details of the person discharging managerial responsibilities/person closely associated --- ------------------------------------------------------------------------------------------------ a) Name Peter Bream --- ------------------------------------------------------------ ---------------------------------- 2 Reason for the notification --- ------------------------------------------------------------------------------------------------ a) Position/status Director --- ------------------------------------------------------------ ---------------------------------- b) Initial notification/ Amendment Initial notification --- ------------------------------------------------------------ ---------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------------------------------------------ a) Name Venture Life Group plc --- ------------------------------------------------------------ ---------------------------------- b) LEI --- ------------------------------------------------------------ ---------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------------------------------------------ a) Description of the financial instrument, type of instrument Ordinary shares of 0.3p each Identification code GB00BFPM8908 --- ------------------------------------------------------------ ---------------------------------- b) Nature of the transactions Acquisition --- ------------------------------------------------------------ ---------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) 62p 15,000 63.5p 10,000 --- ------------------------------------------------------------ ---------------------------------- d) Aggregated information - Aggregated volume 25,000 - Price 62.6p ---------------------------------------------------------------- ---------------------------------- e) Date of the transaction 7 August 2017 --- ------------------------------------------------------------ ---------------------------------- f) Place of the transaction London Stock Exchange, AIM Market --- ------------------------------------------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFFETLIDIID
(END) Dow Jones Newswires
August 07, 2017 11:24 ET (15:24 GMT)
1 Year Venture Life Chart |
1 Month Venture Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions